BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23051960)

  • 1. Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution.
    Barlin JN; Wysham WZ; Ferda AM; Khoury-Collado F; Cassella DK; Alektiar KM; Hensley ML; Chi DS; Barakat RR; Abu-Rustum NR
    Int J Gynecol Cancer; 2012 Nov; 22(9):1527-31. PubMed ID: 23051960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: a single institution study.
    Gayar OH; Patel S; Schultz D; Mahan M; Rasool N; Elshaikh MA
    Int J Gynecol Cancer; 2014 Jan; 24(1):97-101. PubMed ID: 24264358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma.
    Xu Y; Burmeister C; Hanna RK; Munkarah A; Elshaikh MA
    Int J Gynecol Cancer; 2016 Jul; 26(6):1137-42. PubMed ID: 27206283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable outcome between endometrioid and non-endometrioid tumors in patients with early-stage high-grade endometrial cancer.
    Reynaers EA; Ezendam NP; Pijnenborg JM
    J Surg Oncol; 2015 May; 111(6):790-4. PubMed ID: 25900897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
    Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K
    Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Padilla-Iserte P; Lago V; Tauste C; Díaz-Feijoo B; Gil-Moreno A; Oliver R; Coronado P; Martín-Salamanca MB; Pantoja-Garrido M; Marcos-Sanmartin J; Gilabert-Estellés J; Lorenzo C; Cazorla E; Roldán-Rivas F; Rodríguez-Hernández JR; Sánchez L; Muruzábal JC; Hervas D; Domingo S;
    Am J Obstet Gynecol; 2021 Jan; 224(1):65.e1-65.e11. PubMed ID: 32693096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
    Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of perioperative morbidity, perioperative mortality, and disease-specific survival in elderly women (>or=70 years) versus younger women (<70 years) with endometrioid endometrial cancer.
    Vaknin Z; Ben-Ami I; Schneider D; Pansky M; Halperin R
    Int J Gynecol Cancer; 2009 Jul; 19(5):879-83. PubMed ID: 19574777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.